Atlas Trials

A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Clinical trial NCT03478683 · COMPLETED

Trial details

NCT number
NCT03478683
Sponsor
GlaxoSmithKline
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Pulmonary Disease, Chronic Obstructive
Start date
2018-06-25
Primary completion
2019-03-14
Enrollment
729

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.